tiprankstipranks
Takeda Pharmaceutical Company (TAK)
NYSE:TAK
US Market
TAK
Takeda Pharmaceutical Company
RESEARCH TOOLSreports
Want to see TAK full AI Analyst Report?

Takeda Pharmaceutical Company (TAK) Cash flow

1,354 Followers

Takeda Pharmaceutical Company Cash Flow

TAK's free cash flow for Q3 2025 was ¥317.47B. For the 2025 fiscal year, TAK's free cash flow was decreased by ¥620.77B and operating cash flow was ¥360.04B. See a summary of the company’s cash flow.
Cash Flow
Mar 25Mar 24Mar 23Mar 22Mar 21
Operating Cash Flow
¥ 1.06T¥ 716.34B¥ 977.16B¥ 1.12T¥ 1.01T
Investing Cash Flow
¥ -367.06B¥ -463.86B¥ -607.10B¥ -198.13B¥ 393.53B
Financing Cash Flow
¥ -751.42B¥ -354.42B¥ -709.15B¥ -1.07T¥ -1.09T
End Cash Position
¥ 385.11B¥ 457.80B¥ 533.53B¥ 849.70B¥ 966.22B
Free Cash Flow
¥ 856.39B¥ 235.61B¥ 343.47B¥ 937.07B¥ 774.46B
Currency in JPY

Takeda Pharmaceutical Company Cash Flow